Segundo a BBC, os novos medicamentos, chamados REGN-EB3 e mAb114, atuam atacando o vírus Ebola com anticorpos, neutralizando seu impacto nas células humanas.
According to the BBC, the new drugs, named REGN-EB3 and mAb114, work by attacking the Ebola virus with antibodies, neutralising its impact on human cells.